Egbert Oosterwijk

13.7k total citations · 1 hit paper
278 papers, 9.0k citations indexed

About

Egbert Oosterwijk is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Egbert Oosterwijk has authored 278 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Molecular Biology, 97 papers in Pulmonary and Respiratory Medicine and 86 papers in Surgery. Recurrent topics in Egbert Oosterwijk's work include Renal cell carcinoma treatment (77 papers), Renal and related cancers (62 papers) and Radiopharmaceutical Chemistry and Applications (45 papers). Egbert Oosterwijk is often cited by papers focused on Renal cell carcinoma treatment (77 papers), Renal and related cancers (62 papers) and Radiopharmaceutical Chemistry and Applications (45 papers). Egbert Oosterwijk collaborates with scholars based in Netherlands, United States and Germany. Egbert Oosterwijk's co-authors include Otto C. Boerman, Peter F.A. Mulders, Wim J.G. Oyen, Jeannette Oosterwijk‐Wakka, Jack A. Schalken, Frans H.M. Corstens, Stefan Sleijfer, C. B. H. W. Lamers, Wout Feitz and F.M.J. Debruyne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Egbert Oosterwijk

274 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

2013 561 citations Egbert Oosterwijk et al. profile →

Peers

Countries citing papers authored by Egbert Oosterwijk

Since Specialization

Citations

This map shows the geographic impact of Egbert Oosterwijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egbert Oosterwijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egbert Oosterwijk more than expected).

Fields of papers citing papers by Egbert Oosterwijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egbert Oosterwijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egbert Oosterwijk. The network helps show where Egbert Oosterwijk may publish in the future.

Co-authorship network of co-authors of Egbert Oosterwijk

This figure shows the co-authorship network connecting the top 25 collaborators of Egbert Oosterwijk. A scholar is included among the top collaborators of Egbert Oosterwijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egbert Oosterwijk. Egbert Oosterwijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections 2023 ·Journal for ImmunoTherapy of Cancer ·Jelmer H. van Puffelen, Boris Novakovic, Liesbeth van Emst, (unknown), Tahlita C.M. Zuiverloon, (unknown), J. Alfred Witjes, Tessel E. Galesloot, Alina Vrieling, Katja K.H. Aben, Lambertus A. Kiemeney, Egbert Oosterwijk, Mihai G. Netea, Joost L. Boormans, Antoine G. van der Heijden, Leo A. B. Joosten, Sita H. Vermeulen	27
2	Potential of Estradiol‐Functionalized Polyisocyanide Hydrogels for Stimulating Tissue Regeneration of the Pelvic Floor 2023 ·Advanced Therapeutics ·(unknown), (unknown), (unknown), Roel Hammink, Jan‐Paul Roovers, Zeliha Güler, Egbert Oosterwijk, Paul H. J. Kouwer	5
3	Growth Factor Immobilization to Synthetic Hydrogels: Bioactive bFGF‐Functionalized Polyisocyanide Hydrogels 2023 ·Advanced Healthcare Materials ·(unknown), (unknown), (unknown), Jan‐Paul Roovers, Zeliha Güler, Egbert Oosterwijk, Paul H. J. Kouwer	13
4	Molecular Landscape of Pelvic Organ Prolapse Provides Insights into Disease Etiology 2023 ·International Journal of Molecular Sciences ·Kirsten B. Kluivers, (unknown), Alejandra M. Ruiz‐Zapata, (unknown), Rufus Cartwright, Manon H. Kerkhof, (unknown), Ward De Witte, Jakub Pecanka, Lambertus A. Kiemeney, Sita H. Vermeulen, Jelle J. Goeman, Kristina Allen‐Brady, Egbert Oosterwijk, Geert Poelmans	5
5	A Temperature‐Based Easy‐Separable (TempEasy) 3D Hydrogel Coculture System 2022 ·Advanced Healthcare Materials ·(unknown), Wen Chen, Dorien M. Tiemessen, Egbert Oosterwijk, Paul H. J. Kouwer	11
6	Lysine methyltransferase G9a is an important modulator of trained immunity 2021 ·Clinical & Translational Immunology ·Vera P. Mourits, Jelmer H. van Puffelen, Boris Novakovic, Mariolina Bruno, Anaísa V. Ferreira, Rob J.W. Arts, Laszlo Groh, Tania O. Crișan, Jelle Zwaag, Elisa Jentho, Matthijs Kox, Peter Pickkers, Frank L. van de Veerdonk, Sebastian Weis, Egbert Oosterwijk, Sita H. Vermeulen, Mihai G. Netea, Leo A. B. Joosten	30
7	Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform 2021 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Egbert Oosterwijk, Johan Nilvebrant, Sander C.G. Leeuwenburgh, Roland Brock, Wouter P. R. Verdurmen	6
8	Therapeutic efficacy and tolerability of [225Ac]Ac-DOTA-hG250 targeted alpha therapy in a clear cell renal cell carcinoma mice model 2020 ·European Urology Open Science ·(unknown), Anke E Kip, Gerben M. Franssen, Egbert Oosterwijk, Aliyah Morgenstern, Frank Bruchertseifer, Michael Wheatcroft, (unknown), Mark Rijpkema, Sandra Heskamp, (unknown)	1
9	Synthetic Extracellular Matrices as a Toolbox to Tune Stem Cell Secretome 2020 ·ACS Applied Materials & Interfaces ·Kaizheng Liu, (unknown), (unknown), Alejandra M. Ruiz‐Zapata, (unknown), (unknown), (unknown), Bram van Cranenbroek, Hans J. P. M. Koenen, Silvia M. Mihăilă, Egbert Oosterwijk, Paul H. J. Kouwer	32
10	Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer 2020 ·Nature Reviews Urology ·Jelmer H. van Puffelen, Samuel T. Keating, Egbert Oosterwijk, Antoine G. van der Heijden, Mihai G. Netea, Leo A. B. Joosten, Sita H. Vermeulen	128
11	Bone tumor–targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells 2020 ·Materials Today Bio ·Robin A. Nadar, Gerben M. Franssen, (unknown), (unknown), (unknown), Egbert Oosterwijk, Michele Iafisco, Nicola Margiotta, Sandra Heskamp, Jeroen J.J.P. van den Beucken, Sander C.G. Leeuwenburgh	19
12	Synthetic Extracellular Matrices with Nonlinear Elasticity Regulate Cellular Organization 2019 ·Biomacromolecules ·Kaizheng Liu, Silvia M. Mihăilă, Alan E. Rowan, Egbert Oosterwijk, Paul H. J. Kouwer	78
13	Reconstruction Strategies of the Ureter and Urinary Diversion Using Tissue Engineering Approaches 2019 ·Tissue Engineering Part B Reviews ·(unknown), Paul K.J.D. de Jonge, Wout Feitz, Egbert Oosterwijk	16
14	Pulmonary Lymphangitis Carcinomatosis of Clear Cell Renal Cell Carcinoma After Angiogenesis Inhibition 2018 ·Gürsah Kats‐Ugurlu, Carla van Herpen, Sasja F. Mulder, Mathias Prokop, (unknown), Peter F.A. Mulders, (unknown), J. Han van Krieken, Egbert Oosterwijk, William P. J. Leenders, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
15	Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy 2017 ·European Urology Focus ·Marlène C.H. Hekman, Mark Rijpkema, Johan F. Langenhuijsen, Otto C. Boerman, Egbert Oosterwijk, Peter F.A. Mulders	52
16	Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study 2016 ·Clinical Cancer Research ·Marlène C.H. Hekman, Otto C. Boerman, (unknown), Desirée L. Bos, Egbert Oosterwijk, (unknown), Peter F.A. Mulders, Mark Rijpkema	34
17	Is There a Need for Smooth Muscle Cell Transplantation in Urethral Reconstruction? 2013 ·Tissue Engineering Part A ·(unknown), (unknown), Dorien M. Tiemessen, Toin H. Van Kuppevelt, Pascal Frey, Egbert Oosterwijk, (unknown), Wout Feitz	16
18	The Effect of Ethylene Oxide Sterilisation, Beta Irradiation and Gamma Irradiation on Collagen Fibril-Based Scaffolds 2011 ·Journal of Tissue Engineering and Regenerative Medicine ·Kaeuis A. Faraj, (unknown), Paul J. Geutjes, Elly M. M. Versteeg, (unknown), Jan Deprest, Hanane Chajra, (unknown), Wouter F.J. Feitz, Egbert Oosterwijk, Willeke F. Daamen, Toin van Kuppevelt	19
19	Targeting of Biliary Cancer with Radiolabeled Chimeric Monoclonal Antibody CG250 2006 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), (unknown), Otto C. Boerman, Ernst J. Postema, Egbert Oosterwijk, (unknown), Frans H.M. Corstens, Wim J.G. Oyen	6
20	Anti-Renal-Cell Carcinoma Chimeric Antibody G250 Facilitates Antibody-Dependent Cellular Cytotoxicity with In Vitro and In Vivo Interleukin-2-Activated Effectors 1996 ·Journal of Immunotherapy ·Jean E. Surfus, Jacquelyn A. Hank, Egbert Oosterwijk, Sydney Welt, Mary J. Lindstrom, Mark R. Albertini, Joan H. Schiller, Paul M. Sondel	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact